Tudor Investment Corp’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-33,559
| Closed | -$83K | – | 3251 |
|
|
2021
Q3 | $83K | Buy |
+33,559
| New | +$83K | ﹤0.01% | 2369 |
|
|
2020
Q4 | – | Sell |
-19,830
| Closed | -$62K | – | 1767 |
|
|
2020
Q3 | $62K | Sell |
19,830
-33,471
| -63% | -$107K | ﹤0.01% | 1209 |
|
|
2020
Q2 | $155K | Sell |
53,301
-26,123
| -33% | -$82.6K | 0.01% | 1055 |
|
|
2020
Q1 | $224K | Sell |
79,424
-34,310
| -30% | -$111K | 0.02% | 793 |
|
|
2019
Q4 | $369K | Sell |
113,734
-18,043
| -14% | -$52.4K | 0.02% | 814 |
|
|
2019
Q3 | $285K | Buy |
+131,777
| New | +$352K | 0.01% | 871 |
|
|
2019
Q2 | – | Sell |
-34,938
| Closed | -$130K | – | 1475 |
|
|
2019
Q1 | $130K | Buy |
34,938
+22,593
| +183% | +$76.3K | 0.01% | 1031 |
|
|
2018
Q4 | $36K | Sell |
12,345
-598
| -5% | -$1.64K | ﹤0.01% | 966 |
|
|
2018
Q3 | $34K | Buy |
+12,943
| New | +$31.8K | ﹤0.01% | 1054 |
|
|
2018
Q2 | – | Sell |
-21,351
| Closed | -$63K | – | 1358 |
|
|
2018
Q1 | $63K | Buy |
+21,351
| New | +$58.3K | ﹤0.01% | 943 |
|
|
2017
Q2 | – | Sell |
-213,284
| Closed | -$484K | – | 1614 |
|
|
2017
Q1 | $484K | Sell |
213,284
-79,116
| -27% | -$175K | 0.01% | 706 |
|
|
2016
Q4 | $620K | Buy |
292,400
+202,100
| +224% | +$564K | 0.02% | 607 |
|
|
2016
Q3 | $303K | Buy |
+90,300
| New | +$287K | 0.01% | 1012 |
|
|
2016
Q2 | – | Sell |
-87,100
| Closed | -$290K | – | 2134 |
|
|
2016
Q1 | $290K | Sell |
87,100
-38,800
| -31% | -$121K | 0.01% | 1320 |
|
|
2015
Q4 | $446K | Buy |
125,900
+81,000
| +180% | +$339K | 0.01% | 977 |
|
|
2015
Q3 | $226K | Sell |
44,900
-42,100
| -48% | -$241K | 0.01% | 1265 |
|
|
2015
Q2 | $559K | Sell |
87,000
-31,200
| -26% | -$209K | 0.02% | 712 |
|
|
2015
Q1 | $832K | Buy |
118,200
+49,900
| +73% | +$361K | 0.03% | 459 |
|
|
2014
Q4 | $527K | Sell |
68,300
-57,600
| -46% | -$456K | 0.02% | 693 |
|
|
2014
Q3 | $940K | Buy |
125,900
+75,300
| +149% | +$699K | 0.03% | 324 |
|
|
2014
Q2 | $490K | Sell |
50,600
-31,800
| -39% | -$283K | 0.02% | 549 |
|
|
2014
Q1 | $685K | Sell |
82,400
-12,000
| -13% | -$103K | 0.03% | 361 |
|
|
2013
Q4 | $797K | Buy |
94,400
+65,500
| +227% | +$552K | 0.04% | 298 |
|
|
2013
Q3 | $230K | Sell |
28,900
-37,200
| -56% | -$299K | 0.01% | 692 |
|
|
2013
Q2 | $510K | Buy |
+66,100
| New | +$515K | 0.04% | 321 |
|
Tudor Investment Corp's PDLI Position: Q4 2021 in Review
Tudor Investment Corp sold out of PDL BioPharma, Inc. (PDLI) in Q4 2021, closing a stake of 33,559 shares — an estimated $83K sold.
Tudor Investment Corp first reported a position in PDLI in Q2 2013 and held it in 25 quarters. The position peaked at $940K in Q3 2014. 5 funds tracked by Wall St. Rank hold PDLI as of Q4 2021.
- Tudor Investment Corp reported no remaining PDL BioPharma, Inc. position as of Q4 2021 after selling out during the quarter.
- Tudor Investment Corp sold 33,559 PDL BioPharma, Inc. shares in Q4 2021, an estimated $83K.
- Tudor Investment Corp first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 25 quarters.
- Tudor Investment Corp's PDL BioPharma, Inc. position peaked at $940K in Q3 2014.
- 5 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2021.
Based on Tudor Investment Corp's 13F filing for Q4 2021, filed 14 Feb 2022.